Annovis Bio announces special shareholder meeting

• Annovis Bio will hold a virtual special shareholder meeting in October 2026.
• Vote on a charter amendment to double authorized common shares to 140,000,000, increase preferred authorization to 10,000,000.
• Consider ratifying the amended 2019 Equity Incentive Plan, setting the share reserve at 5,500,000, raising the annual grant cap to 600,000.
• Also seeks approval to adjourn the meeting if needed to secure additional votes on the share authorization, equity plan items.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-100460), on August 25, 2026, and is solely responsible for the information contained therein.